Tandem Diabetes Care ( TNDM 4.25%) had some encouraging news to report on the regulatory front Thursday, and after it hit the ...

Tandem and Eli Lilly carried out trials to demonstrate the advantages of using Lyumjev in combination with Control-IQ ...

Tandem Diabetes Care (Nasdaq:TNDM) announced today that it received clearance for the use of rapid-acting insulin with its ...

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that ...

Tandem Diabetes TNDM is gaining from continued product innovations. Yet, rising costs put pressure on margins. The stock ...

For people with type 1 diabetes, management burden including suboptimal insulin preparations remains a major barrier to ...

Capital World Investors (Trades, Portfolio) executed a significant transaction by reducing their holdings in Tandem Diabetes ...

Despite insufficient data, writing panel will give recommendations for preparation, transfer, and follow-up for youth with ...

Consuming more ultraprocessed foods could mean a greater risk for type 2 diabetes, according to new research. Experts share ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Sanofi (SNYNF – Research Report) and Tandem ...

A recent study from Western Sydney University has shown that a simple change in how healthcare providers manage type 2 ...

An investigational once-weekly insulin was noninferior to a daily option for patients with type 2 diabetes, but proved risky ...